195 related articles for article (PubMed ID: 23900217)
21. Decreased expression of PinX1 protein predicts poor prognosis of colorectal cancer patients receiving 5-FU adjuvant chemotherapy.
Deng W; Jiao N; Li N; Wan X; Luo S; Zhang Y
Biomed Pharmacother; 2015 Jul; 73():1-5. PubMed ID: 26211574
[TBL] [Abstract][Full Text] [Related]
22. Prognostic impact of orotate phosphoribosyl transferase among 5-fluorouracil metabolic enzymes in resectable colorectal cancers treated by oral 5-fluorouracil-based adjuvant chemotherapy.
Ochiai T; Nishimura K; Noguchi H; Kitajima M; Tsukada A; Watanabe E; Nagaoka I; Futagawa S
Int J Cancer; 2006 Jun; 118(12):3084-8. PubMed ID: 16425285
[TBL] [Abstract][Full Text] [Related]
23. Repression of chondrogenesis through binding of notch signaling proteins HES-1 and HEY-1 to N-box domains in the COL2A1 enhancer site.
Grogan SP; Olee T; Hiraoka K; Lotz MK
Arthritis Rheum; 2008 Sep; 58(9):2754-63. PubMed ID: 18759300
[TBL] [Abstract][Full Text] [Related]
24. Antagonistic regulation of p57kip2 by Hes/Hey downstream of Notch signaling and muscle regulatory factors regulates skeletal muscle growth arrest.
Zalc A; Hayashi S; Auradé F; Bröhl D; Chang T; Mademtzoglou D; Mourikis P; Yao Z; Cao Y; Birchmeier C; Relaix F
Development; 2014 Jul; 141(14):2780-90. PubMed ID: 25005473
[TBL] [Abstract][Full Text] [Related]
25. Associations between genetic polymorphisms of epidermal growth factor receptor (EGFR) and survival of colorectal cancer (CRC) patients treated with 5-fluorouracil-based chemotherapy.
Lai CY; Sung FC; Hsieh LL; Tang R; Chiou HY; Wu FY; Yeh CC
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S599-606. PubMed ID: 23800895
[TBL] [Abstract][Full Text] [Related]
26. Notch receptor and effector expression in von Hippel-Lindau disease-associated central nervous system hemangioblastomas.
Merrill MJ; Edwards NA; Lonser RR
J Neurosurg; 2011 Sep; 115(3):512-7. PubMed ID: 21663414
[TBL] [Abstract][Full Text] [Related]
27. Notch signaling modulates hypoxia-induced neuroendocrine differentiation of human prostate cancer cells.
Danza G; Di Serio C; Rosati F; Lonetto G; Sturli N; Kacer D; Pennella A; Ventimiglia G; Barucci R; Piscazzi A; Prudovsky I; Landriscina M; Marchionni N; Tarantini F
Mol Cancer Res; 2012 Feb; 10(2):230-8. PubMed ID: 22172337
[TBL] [Abstract][Full Text] [Related]
28. A prospective, blinded analysis of thymidylate synthase and p53 expression as prognostic markers in the adjuvant treatment of colorectal cancer.
Popat S; Chen Z; Zhao D; Pan H; Hearle N; Chandler I; Shao Y; Aherne W; Houlston R
Ann Oncol; 2006 Dec; 17(12):1810-7. PubMed ID: 16971666
[TBL] [Abstract][Full Text] [Related]
29. Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis.
Zheng X; Tsuchiya K; Okamoto R; Iwasaki M; Kano Y; Sakamoto N; Nakamura T; Watanabe M
Inflamm Bowel Dis; 2011 Nov; 17(11):2251-60. PubMed ID: 21987298
[TBL] [Abstract][Full Text] [Related]
30. [Expression pattern and clinical significance of hairy enhancer of split 1 in colorectal cancer].
Jin HY; Xu JH; Wang XF; Ding YJ
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(41):2891-4. PubMed ID: 22333607
[TBL] [Abstract][Full Text] [Related]
31. Mismatch repair protein expression is an independent prognostic factor in sporadic colorectal cancer.
Ohrling K; Edler D; Hallström M; Ragnhammar P
Acta Oncol; 2010 Aug; 49(6):797-804. PubMed ID: 20307245
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of neurone glial-related cell adhesion molecule is an independent predictor of poor prognosis in advanced colorectal cancer.
Chan JY; Ong CW; Salto-Tellez M
Cancer Sci; 2011 Oct; 102(10):1855-61. PubMed ID: 21718388
[TBL] [Abstract][Full Text] [Related]
33. Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer.
Negri FV; Wotherspoon A; Cunningham D; Norman AR; Chong G; Ross PJ
Ann Oncol; 2005 Aug; 16(8):1305-10. PubMed ID: 15857840
[TBL] [Abstract][Full Text] [Related]
34. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy.
Murcia O; Juárez M; Rodríguez-Soler M; Hernández-Illán E; Giner-Calabuig M; Alustiza M; Egoavil C; Castillejo A; Alenda C; Barberá V; Mangas-Sanjuan C; Yuste A; Bujanda L; Clofent J; Andreu M; Castells A; Llor X; Zapater P; Jover R
PLoS One; 2018; 13(9):e0203051. PubMed ID: 30188916
[TBL] [Abstract][Full Text] [Related]
35. Loss of Hes1 expression is associated with poor prognosis in colorectal adenocarcinoma.
Ahadi M; Andrici J; Sioson L; Sheen A; Clarkson A; Gill AJ
Hum Pathol; 2016 Nov; 57():91-97. PubMed ID: 27476040
[TBL] [Abstract][Full Text] [Related]
36. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
Kralovánszky J; Adleff V; Hitre E; Pap E; Réti A; Komlósi V; Budai B
Magy Onkol; 2007; 51(2):113-25. PubMed ID: 17660867
[TBL] [Abstract][Full Text] [Related]
37. Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy.
Edler D; Glimelius B; Hallström M; Jakobsen A; Johnston PG; Magnusson I; Ragnhammar P; Blomgren H
J Clin Oncol; 2002 Apr; 20(7):1721-8. PubMed ID: 11919227
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of TRAIL-R1 and TRAIL-R3 expression in metastatic colorectal carcinomas.
Granci V; Bibeau F; Kramar A; Boissière-Michot F; Thézénas S; Thirion A; Gongora C; Martineau P; Del Rio M; Ychou M
Eur J Cancer; 2008 Oct; 44(15):2312-8. PubMed ID: 18755584
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of Notch pathway molecules in oral squamous cell carcinoma.
Hijioka H; Setoguchi T; Miyawaki A; Gao H; Ishida T; Komiya S; Nakamura N
Int J Oncol; 2010 Apr; 36(4):817-22. PubMed ID: 20198324
[TBL] [Abstract][Full Text] [Related]
40. SMAD4 levels and response to 5-fluorouracil in colorectal cancer.
Alhopuro P; Alazzouzi H; Sammalkorpi H; Dávalos V; Salovaara R; Hemminki A; Järvinen H; Mecklin JP; Schwartz S; Aaltonen LA; Arango D
Clin Cancer Res; 2005 Sep; 11(17):6311-6. PubMed ID: 16144935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
